Literature DB >> 2226475

Animal models as predictors of the safety and efficacy of antibiotics.

O Zak1, T O'Reilly.   

Abstract

As opposed to the testing of safety, the testing of the efficacy of antibiotics in animals is not specified in any directives or guidelines and not explicitly required by regulatory authorities. There exists, however, no doubt that in the evaluation of new compounds testing of both safety and efficacy forms an essential link between in vitro tests and clinical trials. It is inconceivable that clinicians would be prepared to conduct a trial in patients without evidence of the efficacy of the antibiotic in question in an appropriate animal model of infection. Both the models for testing safety and those for testing efficacy suffer from a number of shortcomings. If investigators are aware of these deficiencies and take them into account when interpreting the results, the predictive value of the models can be significantly enhanced.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226475     DOI: 10.1007/bf01964286

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Animal models in the assessment of antimicrobial agents.

Authors:  F O'Grady
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

Review 2.  A review of the penetration of antibiotics into CSF and its clinical significance.

Authors:  R Norrby
Journal:  Scand J Infect Dis Suppl       Date:  1978

3.  A review of models for the therapy of experimental infections.

Authors:  M G Bergeron
Journal:  Scand J Infect Dis Suppl       Date:  1978

4.  Experimental osteomyelitis. I. A description of the model.

Authors:  C W Norden
Journal:  J Infect Dis       Date:  1970-11       Impact factor: 5.226

5.  The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitis.

Authors:  W M Scheld; M G Tauber; O Zak; M A Sande
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

6.  Fleming's discovery.

Authors:  E P Abraham
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

Review 7.  In vivo evaluation of antibacterial chemotherapeutic substances.

Authors:  A K Miller
Journal:  Adv Appl Microbiol       Date:  1971       Impact factor: 5.086

8.  Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis.

Authors:  M G Täuber; H Khayam-Bashi; M A Sande
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

9.  Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.

Authors:  C M Nolan; C Ulmer
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

10.  Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis.

Authors:  M H Lebel; M J Hoyt; G H McCracken
Journal:  J Pediatr       Date:  1989-06       Impact factor: 4.406

View more
  4 in total

1.  Animal models in the evaluation of antimicrobial agents.

Authors:  O Zak; T O'Reilly
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 2.  Beige mouse model for Mycobacterium avium complex disease.

Authors:  P R Gangadharam
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

Review 3.  Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules.

Authors:  A Heikkilä; R Erkkola
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

4.  Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa.

Authors:  Cristina Cigana; Serena Ranucci; Alice Rossi; Ida De Fino; Medede Melessike; Alessandra Bragonzi
Journal:  Eur Respir J       Date:  2020-03-05       Impact factor: 16.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.